China NT Pharma Group Co., Ltd. ( (HK:1011) ) just unveiled an update.
China NT Pharma Group Co., Ltd. has announced a major transaction involving the acquisition of 100% of the issued shares in certain target companies. The acquisition, valued at approximately RMB116.2 million, will be financed through the issuance of consideration shares under a specific mandate, pending shareholder approval. This move is classified as a major transaction under the Hong Kong Stock Exchange’s listing rules, necessitating reporting and shareholder approval. The acquisition aims to expand the company’s operational scope, although its completion is contingent upon meeting certain conditions.
More about China NT Pharma Group Co., Ltd.
YTD Price Performance: 48.15%
Average Trading Volume: 387,364
Technical Sentiment Signal: Hold
Current Market Cap: HK$269.7M
See more data about 1011 stock on TipRanks’ Stock Analysis page.